<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940826-1-00040</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4702 -->  <!-- PJG ITAG l=11 g=1 f=1 --> Typically, a patient undergoes dialysis three times a week. A facility may furnish a substantial number of treatments to patients who dialyze less frequently than three times a week. As a result, the facility typically has higher per treatment cost because the treatments involve increased labor or supplies. When this occurs, a facility may apply for an exception to the composite rate.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> Organ Acquisition Costs  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Under &sect;412.113, Medicare pays for heart, kidney, and liver acquisition costs incurred by transplant centers on a reasonable cost basis. Currently, Medicare-certified transplant centers compute Medicare acquisition costs for hearts and livers on Supplemental Worksheet D&hyph;6 of the Hospital Cost Report (Form HCFA&hyph;2552). The average acquisition costs of hearts and livers transplanted in patients other than Medicare beneficiaries are deducted from the total acquisition costs for all hearts and livers. Medicare reimburses the remaining balance as program costs for these organs. Based on recent cost analyses, we are concerned about the very high Medicare costs associated with acquiring a small number of hearts and livers. As a result, we propose to change the method of computing heart and liver acquisition costs to more accurately determine the costs of acquiring organs transplanted in Medicare recipients. The method we propose for computing acquisition costs for hearts and livers conforms to the method used for kidneys because the kidney formula more fairly accounts for Medicare's portion of such costs, including organ wastage. The kidney formula is specified in &sect;413.202.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> II. Proposed Revisions  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> End Stage Renal Disease Payment Exception Requests  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> On several occasions, we have denied exception requests based on application of the criteria contained in our PRM, and the facilities have appealed the denials; subsequently some denials have been overturned by the Provider Reimbursement Review Board (PRRB) because the PRRB is not bound by the guidelines in the PRM. Therefore, we are proposing to place in regulations the specific requirements for determining exceptions. We are proposing the conditions contained in the PRM, with explanations in this preamble, that a facility must meet to qualify for a payment exception and the criteria that we use to evaluate whether the facility meets the conditions.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> We propose to revise 42 CFR Part 413, Subpart H, Payment for ESRD Services. Currently, all our rules for payment for covered outpatient maintenance dialysis treatments are in &sect;413.170. We propose to reorganize the content of Subpart H and divide existing &sect;413.170 into several smaller sections so that readers can more easily locate specific topics.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Following is a list of the new sections:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 2,L2,tp0,i1,s200,xs60 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=95 g=1 f=1 --> &blank; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1New section  <!-- PJG 007 0150 intable --> 1Old section  <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> 413.170&blank;Scope  <!-- PJG 007 0104 intable --> 413.170(a)  <!-- PJG 0012 frnewline --> 413.172&blank;Principles of Prospective Payment  <!-- PJG 007 0104 intable --> 413.170(b)  <!-- PJG 0012 frnewline --> 413.174&blank;Prospective rates for hospital based and independent ESRD facilities  <!-- PJG 007 0104 intable --> 413.170(c)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 413.176&blank;Amount of payments  <!-- PJG 007 0104 intable --> 413.170(d)  <!-- PJG 0012 frnewline --> 413.178&blank;Bad debts  <!-- PJG 007 0104 intable --> 413.170(e)  <!-- PJG 0012 frnewline --> 413.180&blank;Procedures for requesting exceptions to payment rates  <!-- PJG 007 0104 intable --> 413.170(f) <!-- PJG 0012 frnewline --> 413.182&blank;Criteria for approval of exception requests  <!-- PJG 007 0104 intable --> 413.170(g)  <!-- PJG 0012 frnewline --> 413.184&blank;Payment exception: Atypical service intensity (patient mix)  <!-- PJG 007 0104 intable --> 413.170(g)(1)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 413.186&blank;Payment exception: Isolated essential facility  <!-- PJG 007 0104 intable --> 413.170(g)(2)  <!-- PJG 0012 frnewline --> 413.188&blank;Payment exception: Extraordinarycircumstances  <!-- PJG 007 0104 intable --> 413.170(g)(4)  <!-- PJG 0012 frnewline --> 413.190&blank;Payment exception: Self-dialysistraining costs  <!-- PJG 007 0104 intable --> 413.170(g)(5)  <!-- PJG 0012 frnewline --> 413.192&blank;Payment exception: Frequency of dialysis  <!-- PJG 007 0104 intable --> 413.170(g)(6)  <!-- PJG 0012 frnewline --> 413.194&blank;Appeals  <!-- PJG 007 0104 intable --> 413.170(h)  <!-- PJG 0012 frnewline --> 413.196&blank;Notification of changes in rate-setting methodologies and payment rates  <!-- PJG 007 0104 intable --> 413.170(i)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 413.198&blank;Recordkeeping and cost reporting requirements for outpatient maintenance dialysis  <!-- PJG 007 0104 intable --> 413.174  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 413.200&blank;Payment of independent organ procurement organizations  <!-- PJG 0012 frnewline --> and histocompatibility laboratories  <!-- PJG 007 0104 intable --> 413.178  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 413.202&blank;Organ procurement organizations' (OPOs') or transplant centers' costs for kidneys sent to foreign countries or transplanted  <!-- PJG 0012 frnewline --> in patients other than Medicare beneficiaries  <!-- PJG 007 0104 intable --> 413.179  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> Below we discuss the proposed content of Subpart H.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            